Raptor Pharmaceutical announces proposed public offering of common stock
Raptor announced it has commenced an underwritten public offering of $75 million of shares of its common stock. The company is expected to grant underwriters an option for a period of 30 days to purchase up to an additional 15 percent of the number of shares of common stock. March 30, 2015